Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-18-064322

10% owner bought 40,198 shares at an average $24.93 ($1,002,194)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vertex Pharmaceuticals (Europe) Ltd 10% owner 2018-12-26 Purchase +12,737 $24.89 $317,077 5,353,479 D
Vertex Pharmaceuticals (Europe) Ltd 10% owner 2018-12-27 Purchase +27,461 $24.95 $685,116 5,380,940 D
Open-market purchases · 40,198 sh · avg $24.93 · $1,002,194
Loading xslF345X03/doc4.xml…